What Gilead Is Getting Through The Acquisition Of Arcellx
Source: SeekingAlpha
2026-02-23 11:46:56 ET
M&A is back in the biotech industry. After a disappointing January and almost no activity to date in February, Gilead ( GILD ) brings some joy back with up to $7.8 billion acquisition of partner Arcellx ( ACLX )....
Read the full article on Seeking Alpha
For further details see:
What Gilead Is Getting Through The Acquisition Of Arcellx
Legend Biotech Corporation
NASDAQ: LEGN
LEGN Trading
2.23% G/L:
$19.495 Last:
785,081 Volume:
$19.205 Open:
LEGN Latest News
March 10, 2026 07:00:00 am
Legend Biotech Reports Fourth Quarter and Full Year 2025 Results and Recent Highlights
LEGN Stock Data
$3,309,357,827
166,569,786
N/A
63
N/A
Biotechnology & Life Sciences
Healthcare
US
Somerset
